Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of Apoptosis
Open Access
- 1 June 2004
- journal article
- Published by Elsevier
- Vol. 279 (25), 26287-26299
- https://doi.org/10.1074/jbc.m400963200
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-κB, Mitogen-activated Protein Kinases, and ApoptosisPublished by Elsevier ,2003
- Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cellsInternational Journal of Cancer, 2003
- H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosisOncogene, 2003
- Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancerOncogene, 2001
- NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesisOncogene, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Regulation of NF-κB RelA Phosphorylation and Transcriptional Activity by p21 and Protein Kinase Cζ in Primary Endothelial CellsJournal of Biological Chemistry, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Ras-dependent growth factor regulation of MEK kinase in PC12 cellsScience, 1994